Clinical Trials Browser

Axitinib × Endocrine × 90 days × Clear all

NCT03839498 2026-03-02

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

Phase 2 Active not recruiting

Paraganglioma, Pheochromocytoma